Alpa Laboratories (ALPA.NS) Stock Price

Alpa Laboratories Price

CLOSED
56.99
​
Market closed

Over the last 19 years Alpa Laboratories grew revenue by 2.5% annually, reaching 1.12 B INR. Earnings per share have grown at 8.7% per year over the last 19 years. For Alpa Laboratories, the net margin of 17.3% is up versus 7.4% a few years ago.

Alpa Laboratories stock price

Access this data via the Eulerpool API

Alpa Laboratories business model & stock analysis

Alpa Laboratories Ltd. is a pharmaceutical holding company, which engages in the manufactures of drugs and chemicals. The company is headquartered in Indore, Madhya Pradesh and currently employs 318 full-time employees. The company went IPO on 2007-08-01. The firm is engaged in manufacturing pharmaceutical finished dosage forms. Its product range includes a variety of generic and over the counter (OTC) drugs in various finished dosage forms for both human and veterinary use. For human use it offers capsules such as Ampicillin Capsule IP/BP, Amoxycillin Trihydrate Capsule IP/BP, Cloxacillin Capsules IP/BP and Piroxicam Capsules IP BP; creams, gels and ointments, which include Lidocaine Hydrochloride Jelly IP/USP, Nitrofurazone Cream USP, Miconazole Cream IP/BP and Clobetasole Ointment/Cream BP; ear and eye drops, such as Benzylpenicillin Inj. IP/BP and Benzathine Penicillin Inj. IP/BP, and tablets, such as Albendazole Tablet IP/USP, Paracetamol Tablet IP/BP and Tinidazole Tablets IP/BP. Its veterinary products include boluses, such as Alpamin Bolus and Alpazole Bolus, and injections, such as Atropine Inj. B.Vet.C and others.

Frequently asked questions about Alpa Laboratories

7 analysts currently rate the Alpa Laboratories stock: 6 recommend buying, 1 holding and 0 selling.

Converted at the current exchange rate, the Alpa Laboratories share trades at 0.53 EUR (56.99 INR).

The revenue cannot currently be calculated for Alpa Laboratories.

The profit cannot currently be calculated for Alpa Laboratories.

The P/E ratio cannot be calculated for Alpa Laboratories at the moment.

The P/S cannot be calculated for Alpa Laboratories currently.

The Eulerpool Quality Score for Alpa Laboratories is 4/10.

The ISIN of Alpa Laboratories is INE385I01010. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Alpa Laboratories is ALPA.NS. The ticker symbol is used to trade Alpa Laboratories shares on the stock exchange.

Fair ValueTerminal
52.43 INR
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Pharmaceuticals
Number of shares
Employees
Revenue per Employee
3.54 M INR
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website alpalabs.in
Country
Currency
INR
Initial public offering
Aug 1, 2007
ISIN
INE385I01010
Cusip
Y00937105
Market capitalization
1.20 B INRSmall Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
45.24
P/B Ratio
0.70
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
11.37 %
Last updated Oct 11, 2026, 4:14 AM

Alpa Laboratories Peer Group

Alpa Laboratories FIGI

ALPA:IN · BBG000QJQHJ3ALPA:IB · BBG000QJQHV9ALPA:IS · BBG000QJQJ90